NIP
CBAY

Nicholas Investment Partners’s Cymabay Therapeutics CBAY Stock Holding History

Nicholas Investment Partners’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-434,507
Closed -$10.3M – 229
2023
Q4 		$10.3M Sell
434,507
-1,405,507
-76% -$25M 1.2% 19
2023
Q3 		$27.4M Buy
1,840,014
+1,143,067
+164% +$15.2M 2.05% 12
2023
Q2 		$7.63M Buy
+696,947
New +$6.49M 0.52% 50

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nicholas Investment Partners's CBAY Position: Q1 2024 in Review

Nicholas Investment Partners sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 434,507 shares — an estimated $10.3M sold.

Nicholas Investment Partners first reported a position in CBAY in Q2 2023 and held it in 3 quarters. The position peaked at $27.4M in Q3 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Nicholas Investment Partners reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Nicholas Investment Partners sold 434,507 Cymabay Therapeutics shares in Q1 2024, an estimated $10.3M.
  • Nicholas Investment Partners first reported a position in Cymabay Therapeutics in Q2 2023 and held it in 3 quarters.
  • Nicholas Investment Partners's Cymabay Therapeutics position peaked at $27.4M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Nicholas Investment Partners's 13F filing for Q1 2024, filed 14 May 2024.